BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3448 related articles for article (PubMed ID: 7587740)

  • 1. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF.
    Schmid I; Baldwin GC; Jacobs EL; Isacescu V; Neagos N; Giorgi JV; Glaspy JA
    Cytometry; 1995 Jun; 22(2):103-10. PubMed ID: 7587740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function.
    Smith PD; Lamerson CL; Wong HL; Wahl LM; Wahl SM
    J Immunol; 1990 May; 144(10):3829-34. PubMed ID: 2185314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rhM-CSF expressed in silkworm on cytokine productions and membrane molecule expressions of human monocytes.
    Ji XH; Sun LH; Qin JC; Yao K; Ding RN; Li HD; Zhu DX
    Acta Pharmacol Sin; 2000 Sep; 21(9):797-801. PubMed ID: 11501160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
    Wiltschke C; Krainer M; Wagner A; Linkesch W; Zielinski CC
    Exp Hematol; 1995 May; 23(5):402-6. PubMed ID: 7536681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
    Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
    Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
    Schiller JH; Hank JA; Khorsand M; Storer B; Borchert A; Huseby-Moore K; Burns D; Wesly O; Albertini MR; Wilding G; Sondel PM
    Clin Cancer Res; 1996 Feb; 2(2):319-30. PubMed ID: 9816175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
    Pickl WF; Majdic O; Kohl P; Stöckl J; Riedl E; Scheinecker C; Bello-Fernandez C; Knapp W
    J Immunol; 1996 Nov; 157(9):3850-9. PubMed ID: 8892615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
    Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
    Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
    Saleh MN; Khazaeli MB; Wheeler RH; Bucy RP; Liu T; Everson MP; Munn DH; Schlom J; LoBuglio AF
    Cancer Res; 1995 Oct; 55(19):4339-46. PubMed ID: 7671245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
    Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of survival, proliferation and cell surface antigen expression of human monocytes exposed to macrophage colony-stimulating factor (M-CSF).
    Erickson-Miller CL; Brennan JK; Abboud CN
    Int J Cell Cloning; 1990 Sep; 8(5):346-56. PubMed ID: 2230285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.
    Niitsu N; Hayama M; Okamoto M; Khori M; Higashihara M; Tamaru J; Hirano M
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4077-82. PubMed ID: 15217942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
    Mizuno K; Okamoto H; Horio T
    J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells.
    Du Z; Li Y; Xia H; Irani AM; Schwartz LB
    J Immunol; 1997 Jul; 159(2):838-45. PubMed ID: 9218602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone up-regulates granulocyte-macrophage colony-stimulating factor receptor expression on human monocytes.
    Hawrylowicz CM; Guida L; Paleolog E
    Immunology; 1994 Oct; 83(2):274-80. PubMed ID: 7835947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 173.